Stephen Greene | Scholars@Duke

Stephen Greene
House Staff

Current Appointments & Affiliations

House Staff, Medicine, Cardiology, Medicine

Contact Information

stephen.greene@duke.edu +1 919 684 8111

Research
Selected Grants
- Comparison of Dyspnea Measurement Instruments in Acute Heart Failure awarded by Heart Failure Society of America 2017 - 2019
Publications & Artistic Works
Selected Publications
- Academic Articles
  - Greene, SJ, and Felker, GM. "The Urgency of Doing: Addressing Gaps in Use of Evidence-Based Medical Therapy for Heart Failure." Jacc. Heart Failure 7, no. 1 (January 2019): 22-24. Full Text
  - Gori, M, Canova, P, Calabrese, A, Cioffi, G, Trevisan, R, De Maria, R, Grosu, A, Iacovoni, A, Fontana, A, Ferrari, P, Greene, SJ, Gheorghiade, M, Parati, G, Gavazzi, A, and Senni, M. "Strategy to identify subjects with diabetes mellitus more suitable for selective echocardiographic screening: The DAVID-Berg study." International journal of cardiology 248 (December 2017): 414-420. Full Text
  - Khan, MS, Fonarow, GC, Ahmed, A, Greene, SJ, Vaduganathan, M, Khan, H, Marti, C, Gheorghiade, M, and Butler, J. "Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis." Circulation. Heart failure 10, no. 8 (August 2017). Full Text
  - Ambrosy, AP, Bhatt, AS, Gallup, D, Anstrom, KJ, Butler, J, DeVore, AD, Felker, GM, Fudim, M, Greene, SJ, Hernandez, AF, Kelly, JP, Samsky, MD, and Mentz, RJ. "Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network)." The American journal of cardiology 120, no. 1 (July 2017): 98-105. Full Text
  - Greene, SJ, Vaduganathan, M, and Gheorghiade, M. "Finding the road to recovery: therapeutic and clinical trial implications of dysfunctional viable myocardium in heart failure with reduced ejection fraction." European journal of heart failure 19, no. 7 (July 2017): 870-872. Full Text
  - Greene, SJ, Hernandez, AF, Dunning, A, Ambrosy, AP, Armstrong, PW, Butler, J, Cerbin, LP, Coles, A, Ezekowitz, JA, Metra, M, Starling, RC, Teerlink, JR, Voors, AA, O'Connor, CM, and Mentz, RJ. "Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial." Journal of the American College of Cardiology 69, no. 25 (June 2017): 3029-3039. Full Text
  - Senni, M, Greene, SJ, Butler, J, Fonarow, GC, and Gheorghiade, M. "Drug Development for Heart Failure With Preserved Ejection Fraction: What Pieces Are Missing From the Puzzle?." The Canadian Journal of Cardiology 33, no. 6 (June 2017): 768-776. (Review) Full Text
  - Ambrosy, AP, Cerbin, LP, DeVore, AD, Greene, SJ, Kraus, WE, O'Connor, CM, Piña, IL, Whellan, DJ, Wojdyla, D, Wu, A, and Mentz, RJ. "Aerobic exercise training and general health status in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)trial." American Heart Journal 186 (April 2017): 130-138. Full Text
  - Brown, DA, Perry, JB, Allen, ME, Sabbah, HN, Stauffer, BL, Shaikh, SR, Cleland, JGF, Colucci, WS, Butler, J, Voors, AA, Anker, SD, Pitt, B, Pieske, B, Filippatos, G, Greene, SJ, and Gheorghiade, M. "Expert consensus document: Mitochondrial function as a therapeutic target in heart failure." Nature Reviews. Cardiology 14, no. 4 (April 2017): 238-250. (Review) Full Text
  - Greene, SJ, Epstein, SE, Kim, RJ, Quyyumi, AA, Cole, RT, Anderson, AS, Wilcox, JE, Skopicki, HA, Sikora, S, Verkh, L, Tankovich, NI, Gheorghiade, M, and Butler, J. "Rationale and design of a randomized controlled trial of allogeneic mesenchymal stem cells in patients with nonischemic cardiomyopathy." Journal of cardiovascular medicine (Hagerstown, Md.) 18, no. 4 (April 2017): 283-290. Full Text
  - Greene, SJ, Fonarow, GC, Solomon, SD, Subacius, HP, Ambrosy, AP, Vaduganathan, M, Maggioni, AP, Böhm, M, Lewis, EF, Zannad, F, Butler, J, Gheorghiade, M, and ASTRONAUT Investigators and Coordinators, . "Influence of atrial fibrillation on post-discharge natriuretic peptide trajectory and clinical outcomes among patients hospitalized for heart failure: insights from the ASTRONAUT trial." European Journal of Heart Failure 19, no. 4 (April 2017): 552-562. Full Text
  - Vaduganathan, M, Samman-Tahhan, A, Patel, RB, Kelkar, A, Papadimitriou, L, Georgiopoulou, VV, Greene, SJ, Kalogeropoulos, AP, Peterson, E, Fonarow, GC, Gheorghiade, M, and Butler, J. "Association between funding sources and the scope and outcomes of cardiovascular clinical trials: A systematic review." International Journal of Cardiology 230 (March 2017): 301-303. (Review) Full Text
  - Ambrosy, AP, Cerbin, LP, Armstrong, PW, Butler, J, Coles, A, DeVore, AD, Dunlap, ME, Ezekowitz, JA, Felker, GM, Fudim, M, Greene, SJ, Hernandez, AF, O'Connor, CM, Schulte, P, Starling, RC, Teerlink, JR, Voors, AA, and Mentz, RJ. "Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial." Jacc. Heart Failure 5, no. 1 (January 2017): 1-13. Full Text
  - Ambrosy, AP, Cerbin, LP, Armstrong, PW, Butler, L, Coles, A, DeVore, AD, Dunlap, ME, Ezekowitz, JA, Felker, GM, Fudim, M, Greene, SJ, Hernandez, AF, O'Connor, CM, Schulte, P, Starling, RC, Teerlink, JR, Voors, AA, and Mentz, RJ. "Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes Findings From the ASCEND-HF Trial." JACC-HEART FAILURE 5, no. 1 (January 2017): 3-13. Link to Item
  - Butler, J, Epstein, SE, Greene, SJ, Quyyumi, AA, Sikora, S, Kim, RJ, Anderson, AS, Wilcox, JE, Tankovich, NI, Lipinski, MJ, Ko, Y-A, Margulies, KB, Cole, RT, Skopicki, HA, and Gheorghiade, M. "Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial." Circulation Research 120, no. 2 (January 2017): 332-340. Full Text
  - Ambrosy, AP, Cerbin, LP, Armstrong, PW, Butler, J, Coles, A, DeVore, AD, Dunlap, ME, Ezekowitz, JA, Felker, GM, Fudim, M, Greene, SJ, Hernandez, AF, O'Connor, CM, Schulte, P, Starling, RC, Teerlink, JR, Voors, AA, and Mentz, RJ. "Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From ASCEND-HF." Jacc. Heart Failure (November 30, 2016). Full Text
  - Barroso, MC, Kramer, F, Greene, SJ, Scheyer, D, Köhler, T, Karoff, M, Seyfarth, M, Gheorghiade, M, and Dinh, W. "Serum insulin-like growth factor-1 and its binding protein-7: potential novel biomarkers for heart failure with preserved ejection fraction." BMC cardiovascular disorders 16, no. 1 (October 21, 2016): 199-. Full Text
  - Greene, SJ, Hernandez, AF, Sun, J-L, Metra, M, Butler, J, Ambrosy, AP, Ezekowitz, JA, Starling, RC, Teerlink, JR, Schulte, PJ, Voors, AA, Armstrong, PW, O'Connor, CM, and Mentz, RJ. "Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure)." Circulation. Heart Failure 9, no. 9 (September 2016). Full Text
  - Vaduganathan, M, Patel, RB, Greene, SJ, and Gheorghiade, M. "Targeting the vulnerable phase of heart failure: initiate novel therapies in stable patients prior to hospitalization." European Journal of Heart Failure 18, no. 9 (September 2016): 1190-1192. Full Text
  - Chioncel, O, Collins, SP, Greene, SJ, Ambrosy, AP, Vaduganathan, M, Macarie, C, Butler, J, and Gheorghiade, M. "Natriuretic peptide-guided management in heart failure." Journal of Cardiovascular Medicine (Hagerstown, Md.) 17, no. 8 (August 2016): 556-568. (Review) Full Text
  - "Role of omega-3 polyunsaturated fatty acids after acute coronary syndrome." Giornale Italiano Di Cardiologia 17, no. 7 (July 1, 2016): 3S-10S.
  - Temporelli, PL, Buda, S, and Greene, SJ. "[Role of omega-3 polyunsaturated fatty acids after acute coronary syndrome]." Giornale Italiano Di Cardiologia (2006) 17, no. 7 Suppl 1 (July 2016): 3-10. Full Text
  - Mentz, RJ, Roessig, L, Greenberg, BH, Sato, N, Shinagawa, K, Yeo, D, Kwok, BWK, Reyes, EB, Krum, H, Pieske, B, Greene, SJ, Ambrosy, AP, Kelly, JP, Zannad, F, Pitt, B, and Lam, CSP. "Heart Failure Clinical Trials in East and Southeast Asia: Understanding the Importance and Defining the Next Steps." Jacc. Heart Failure 4, no. 6 (June 2016): 419-427. (Review) Full Text
  - Ambrosy, AP, Khan, H, Udelson, JE, Mentz, RJ, Chioncel, O, Greene, SJ, Vaduganathan, M, Subacuis, HP, Konstam, MA, Swedberg, K, Zannad, F, Maggioni, AP, Gheorghiade, M, and Butler, J. "Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST Trial." Circulation. Heart Failure 9, no. 5 (May 2016). Full Text
  - Gheorghiade, M, Larson, CJ, Shah, SJ, Greene, SJ, Cleland, JGF, Colucci, WS, Dunnmon, P, Epstein, SE, Kim, RJ, Parsey, RV, Stockbridge, N, Carr, J, Dinh, W, Krahn, T, Kramer, F, Wahlander, K, Deckelbaum, LI, Crandall, D, Okada, S, Senni, M, Sikora, S, Sabbah, HN, and Butler, J. "Developing New Treatments for Heart Failure: Focus on the Heart." Circulation. Heart failure 9, no. 5 (May 2016). Full Text
  - Vaduganathan, M, Marti, CN, Mentz, RJ, Greene, SJ, Ambrosy, AP, Subacius, HP, Fonarow, GC, Chioncel, O, Bazari, H, Maggioni, AP, Zannad, F, Konstam, MA, Sato, N, Gheorghiade, M, Butler, J, and EVEREST trial investigators, . "Serum Osmolality and Postdischarge Outcomes After Hospitalization for Heart Failure." The American Journal of Cardiology 117, no. 7 (April 2016): 1144-1150. Full Text
  - Ambrosy, AP, Hernandez, AF, Armstrong, PW, Butler, J, Dunning, A, Ezekowitz, JA, Felker, GM, Greene, SJ, Kaul, P, McMurray, JJ, Metra, M, O'Connor, CM, Reed, SD, Schulte, PJ, Starling, RC, Tang, WHW, Voors, AA, and Mentz, RJ. "The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF." European Journal of Heart Failure 18, no. 3 (March 2016): 306-313. Full Text
  - Samman Tahhan, A, Vaduganathan, M, Kelkar, A, Georgiopoulou, VV, Kalogeropoulos, AP, Greene, SJ, Fonarow, GC, Gheorghiade, M, and Butler, J. "Trends in Heart Failure Clinical Trials From 2001-2012." Journal of cardiac failure 22, no. 3 (March 2016): 171-179. (Review) Full Text
  - Cook, TD, Greene, SJ, Kalogeropoulos, AP, Fonarow, GC, Zea, R, Swedberg, K, Zannad, F, Maggioni, AP, Konstam, MA, Gheorghiade, M, and Butler, J. "Temporal Changes in Postdischarge Mortality Risk After Hospitalization for Heart Failure (from the EVEREST Trial)." The American Journal of Cardiology 117, no. 4 (February 2016): 611-616. Full Text
  - Greene, SJ, Temporelli, PL, Campia, U, Vaduganathan, M, Degli Esposti, L, Buda, S, Veronesi, C, Butler, J, and Nodari, S. "Effects of Polyunsaturated Fatty Acid Treatment on Postdischarge Outcomes After Acute Myocardial Infarction." The American Journal of Cardiology 117, no. 3 (February 2016): 340-346. Full Text
  - Greene, SJ, Sabbah, HN, Butler, J, Voors, AA, Albrecht-Küpper, BE, Düngen, H-D, Dinh, W, and Gheorghiade, M. "Partial adenosine A1 receptor agonism: a potential new therapeutic strategy for heart failure." Heart failure reviews 21, no. 1 (January 2016): 95-102. (Review) Full Text
  - Gheorghiade, M, Greene, SJ, Butler, J, Filippatos, G, Lam, CSP, Maggioni, AP, Ponikowski, P, Shah, SJ, Solomon, SD, Kraigher-Krainer, E, Samano, ET, Müller, K, Roessig, L, Pieske, B, and SOCRATES-REDUCED Investigators and Coordinators, . "Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized Trial." Jama 314, no. 21 (December 2015): 2251-2262. Full Text
  - Chioncel, O, Collins, SP, Greene, SJ, Ambrosy, AP, Vaduganathan, M, Macarie, C, Butler, J, and Gheorghiade, M. "Natriuretic peptide-guided management in heart failure." Journal of cardiovascular medicine (Hagerstown, Md.) (November 7, 2015).
  - Butler, J, Gheorghiade, M, Kelkar, A, Fonarow, GC, Anker, S, Greene, SJ, Papadimitriou, L, Collins, S, Ruschitzka, F, Yancy, CW, Teerlink, JR, Adams, K, Cotter, G, Ponikowski, P, Felker, GM, Metra, M, and Filippatos, G. "In-hospital worsening heart failure." European journal of heart failure 17, no. 11 (November 2015): 1104-1113. (Review) Full Text
  - Ambrosy, AP, Mentz, RJ, Krishnamoorthy, A, Greene, SJ, and Severance, HW. "Identifying Barriers and Practical Solutions to Conducting Site-Based Research in North America: Exploring Acute Heart Failure Trials As a Case Study." Heart failure clinics 11, no. 4 (October 2015): 581-589. (Review) Full Text Open Access Copy
  - Greene, SJ, AlKhawam, L, Ambrosy, AP, Vaduganathan, M, and Mentz, RJ. "Hospitalized Heart Failure in the United States: Lessons Learned from Clinical Trial Populations." Heart failure clinics 11, no. 4 (October 2015): 591-601. (Review) Full Text
  - Greene, SJ, and Fonarow, GC. "Insulin resistance in heart failure: widening the divide between reduced and preserved ejection fraction?." European journal of heart failure 17, no. 10 (October 2015): 991-993. Full Text
  - Khan, H, Greene, SJ, Fonarow, GC, Kalogeropoulos, AP, Ambrosy, AP, Maggioni, AP, Zannad, F, Konstam, MA, Swedberg, K, Yancy, CW, Gheorghiade, M, Butler, J, and EVEREST Trial Investigators, . "Length of hospital stay and 30-day readmission following heart failure hospitalization: insights from the EVEREST trial." European Journal of Heart Failure 17, no. 10 (October 2015): 1022-1031. Full Text
  - Greene, SJ, and Gheorghiade, M. "Same protocol, different continents, different patients: should we continue to conduct global heart failure trials?." European journal of heart failure 17, no. 9 (September 2015): 875-878. Full Text
  - Harinstein, ME, Butler, J, Greene, SJ, Fonarow, GC, Stockbridge, NL, O'Connor, CM, Pfeffer, MA, Mehra, MR, Solomon, SD, Yancy, CW, Fiuzat, M, Mentz, RJ, Collins, SP, McMurray, JJV, Vaduganathan, M, Dunnmon, PM, Rosano, GMC, Dinh, W, Misselwitz, F, Bonow, RO, and Gheorghiade, M. "Site selection for heart failure clinical trials in the USA." Heart failure reviews 20, no. 4 (July 2015): 375-383. Full Text
  - Vaduganathan, M, Butler, J, Roessig, L, Fonarow, GC, Greene, SJ, Metra, M, Cotter, G, Kupfer, S, Zalewski, A, Sato, N, Filippatos, G, and Gheorghiade, M. "Clinical trials in hospitalized heart failure patients: targeting interventions to optimal phenotypic subpopulations." Heart failure reviews 20, no. 4 (July 2015): 393-400. (Review) Full Text
  - Vaduganathan, M, Tahhan, AS, Greene, SJ, Kelkar, AA, Georgiopoulou, VV, Kalogeropoulos, AP, Fonarow, GC, Gheorghiade, M, and Butler, J. "Contemporary cardiovascular device clinical trials (trends and patterns 2001 to 2012)." The American journal of cardiology 116, no. 2 (July 2015): 307-312. Full Text
  - Greene, SJ, Fonarow, GC, Solomon, SD, Subacius, H, Maggioni, AP, Böhm, M, Lewis, EF, Zannad, F, Gheorghiade, M, and ASTRONAUT Investigators and Coordinators, . "Global variation in clinical profile, management, and post-discharge outcomes among patients hospitalized for worsening chronic heart failure: findings from the ASTRONAUT trial." European Journal of Heart Failure 17, no. 6 (June 2015): 591-600. Full Text
  - Echouffo-Tcheugui, JB, Greene, SJ, Papadimitriou, L, Zannad, F, Yancy, CW, Gheorghiade, M, and Butler, J. "Population risk prediction models for incident heart failure: a systematic review." Circulation. Heart failure 8, no. 3 (May 2015): 438-447. (Review) Full Text
  - Greene, SJ, Fonarow, GC, and Butler, J. "REPORT-HF: the unique blend of global heart failure registry and longitudinal cohort study." European Journal of Heart Failure 17, no. 5 (May 2015): 472-474. Full Text
  - Greene, SJ, Fonarow, GC, Vaduganathan, M, Khan, SS, Butler, J, and Gheorghiade, M. "The vulnerable phase after hospitalization for heart failure." Nature Reviews. Cardiology 12, no. 4 (April 2015): 220-229. (Review) Full Text
  - Greene, SJ, and Gheorghiade, M. "Reply: considerations for drug development for heart failure." Journal of the American College of Cardiology 65, no. 10 (March 2015): 1061-1062. (Letter) Full Text
  - Maisel, A, Xue, Y, Greene, SJ, Pang, PS, Januzzi, JL, Piña, IL, DeFilippi, C, and Butler, J. "The potential role of natriuretic peptide-guided management for patients hospitalized for heart failure." Journal of Cardiac Failure 21, no. 3 (March 2015): 233-239. (Review) Full Text
  - Dei Cas, A, Khan, SS, Butler, J, Mentz, RJ, Bonow, RO, Avogaro, A, Tschoepe, D, Doehner, W, Greene, SJ, Senni, M, Gheorghiade, M, and Fonarow, GC. "Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure." Jacc. Heart Failure 3, no. 2 (February 2015): 136-145. (Review) Full Text
  - Greene, SJ, Maggioni, AP, Fonarow, GC, Solomon, SD, Böhm, M, Kandra, A, Prescott, MF, Reimund, B, Hua, TA, Lesogor, A, Zannad, F, Gheorghiade, M, and ASTRONAUT Investigators and Coordinators, . "Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial." European Journal of Heart Failure 17, no. 1 (January 2015): 98-108. Full Text
  - Parrinello, G, Greene, SJ, Torres, D, Alderman, M, Bonventre, JV, Di Pasquale, P, Gargani, L, Nohria, A, Fonarow, GC, Vaduganathan, M, Butler, J, Paterna, S, Stevenson, LW, and Gheorghiade, M. "Water and sodium in heart failure: a spotlight on congestion." Heart failure reviews 20, no. 1 (January 2015): 13-24. (Review) Full Text
  - Vaduganathan, M, Mentz, RJ, Greene, SJ, Senni, M, Sato, N, Nodari, S, Butler, J, and Gheorghiade, M. "Combination decongestion therapy in hospitalized heart failure: loop diuretics, mineralocorticoid receptor antagonists and vasopressin antagonists." Expert review of cardiovascular therapy 13, no. 7 (January 2015): 799-809. (Review) Full Text
  - Vaduganathan, M, Greene, SJ, Ambrosy, AP, Mentz, RJ, Subacius, HP, Chioncel, O, Maggioni, AP, Swedberg, K, Zannad, F, Konstam, MA, Senni, M, Givertz, MM, Butler, J, Gheorghiade, M, and EVEREST trial investigators, . "Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan trial)." The American Journal of Cardiology 114, no. 11 (December 2014): 1713-1721. Full Text
  - Vaduganathan, M, Greene, SJ, Fonarow, GC, Voors, AA, Butler, J, and Gheorghiade, M. "Hemoconcentration-guided diuresis in heart failure." The American Journal of Medicine 127, no. 12 (December 2014): 1154-1159. (Review) Full Text
  - Vaduganathan, M, Greene, SJ, Ambrosy, AP, and Gheorghiade, M. "Lipids, statins, and clinical outcomes in heart failure: rethinking the data." Heart failure reviews 19, no. 6 (November 2014): 695-698. (Review) Full Text
  - Greene, SJ, and Gheorghiade, M. "Matching mechanism of death with mechanism of action: considerations for drug development for hospitalized heart failure." Journal of the American College of Cardiology 64, no. 15 (October 2014): 1599-1601. Full Text
  - Vaduganathan, M, Dei Cas, A, Mentz, RJ, Greene, SJ, Khan, S, Subacius, HP, Chioncel, O, Maggioni, AP, Konstam, MA, Senni, M, Fonarow, GC, Butler, J, Gheorghiade, M, and EVEREST Trial Investigators, . "Mineralocorticoid receptor antagonist use in hospitalized patients with heart failure, reduced ejection fraction, and diabetes mellitus (from the EVEREST Trial)." The American Journal of Cardiology 114, no. 5 (September 2014): 743-750. Full Text
  - Greene, SJ, Shah, AN, Butler, J, Ambrosy, AP, Anker, SD, Chioncel, O, Collins, SP, Dinh, W, Dunnmon, PM, Fonarow, GC, Lam, CSP, Mentz, RJ, Pieske, B, Roessig, L, Rosano, GMC, Sato, N, Vaduganathan, M, and Gheorghiade, M. "Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries." American Heart Journal 168, no. 2 (August 2014): 142-149. Full Text
  - Vaduganathan, M, Greene, SJ, Fonarow, GC, Bonow, RO, Butler, J, and Gheorghiade, M. "Coronary artery disease in patients with heart failure: incidental, coincidental, or a target for therapy?." The American journal of medicine 127, no. 7 (July 2014): 574-578. Full Text
  - Vaduganathan, M, and Greene, SJ. "Influence of Chronic Kidney Disease on Warfarin Therapy for Atrial Fibrillation." Jama 311, no. 24 (June 25, 2014): 2541-2541. Full Text
  - Mentz, RJ, Greene, SJ, Ambrosy, AP, Vaduganathan, M, Subacius, HP, Swedberg, K, Maggioni, AP, Nodari, S, Ponikowski, P, Anker, SD, Butler, J, and Gheorghiade, M. "Clinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial." Circulation. Heart Failure 7, no. 3 (May 2014): 401-408. Full Text
  - Greene, SJ, Alkhawam, L, and Vaduganathan, M. "Dual Antiplatelet Therapy After Stent Implantation." Jama 311, no. 14 (April 9, 2014): 1446-1446. Full Text
  - Ambrosy, AP, Fonarow, GC, Butler, J, Chioncel, O, Greene, SJ, Vaduganathan, M, Nodari, S, Lam, CSP, Sato, N, Shah, AN, and Gheorghiade, M. "The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries." Journal of the American College of Cardiology 63, no. 12 (April 2014): 1123-1133. Full Text
  - Gheorghiade, M, Vaduganathan, M, Greene, SJ, Mentz, RJ, Adams, KF, Anker, SD, Arnold, M, Baschiera, F, Cleland, JGF, Cotter, G, Fonarow, GC, Giordano, C, Metra, M, Misselwitz, F, Mühlhofer, E, Nodari, S, Frank Peacock, W, Pieske, BM, Sabbah, HN, Sato, N, Shah, MR, Stockbridge, NL, Teerlink, JR, van Veldhuisen, DJ, Zalewski, A, Zannad, F, and Butler, J. "Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions." Heart Failure Reviews 19, no. 2 (March 2014): 135-152. Full Text
  - Vaduganathan, M, Greene, SJ, Butler, J, and Gheorghiade, M. "Endpoints for diuresis: are we there yet?." Journal of the American College of Cardiology 63, no. 8 (March 2014): 838-839. (Letter) Full Text
  - "Lipids, statins, and clinical outcomes in heart failure: rethinking the data." Heart Failure Reviews 19, no. 6 (January 1, 2014): 695-698. Full Text
  - Greene, SJ, Vaduganathan, M, Wilcox, JE, Harinstein, ME, Maggioni, AP, Subacius, H, Zannad, F, Konstam, MA, Chioncel, O, Yancy, CW, Swedberg, K, Butler, J, Bonow, RO, Gheorghiade, M, and EVEREST Trial Investigators, . "The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhythm: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study With Tolvaptan) trial." Jacc. Heart Failure 1, no. 6 (December 2, 2013): 488-496. Full Text
  - Greene, SJ, Gheorghiade, M, Vaduganathan, M, Ambrosy, AP, Mentz, RJ, Subacius, H, Maggioni, AP, Nodari, S, Konstam, MA, Butler, J, Filippatos, G, and EVEREST Trial investigators, . "Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial." European Journal of Heart Failure 15, no. 12 (December 2013): 1401-1411. Full Text
  - Vaduganathan, M, Greene, SJ, Ambrosy, AP, Mentz, RJ, Fonarow, GC, Zannad, F, Maggioni, AP, Konstam, MA, Subacius, HP, Nodari, S, Butler, J, Gheorghiade, M, and EVEREST Trial Investigators, . "Relation of serum magnesium levels and postdischarge outcomes in patients hospitalized for heart failure (from the EVEREST Trial)." The American journal of cardiology 112, no. 11 (December 2013): 1763-1769. Full Text
  - Gheorghiade, M, Vaduganathan, M, Fonarow, GC, Greene, SJ, Greenberg, BH, Liu, PP, Massie, BM, Mehra, MR, Metra, M, Zannad, F, Cleland, JGF, van Veldhuisen, DJ, Shah, AN, and Butler, J. "Anticoagulation in heart failure: current status and future direction." Heart Failure Reviews 18, no. 6 (November 2013): 797-813. (Review) Full Text
  - Vaduganathan, M, Greene, SJ, Butler, J, Sabbah, HN, Shantsila, E, Lip, GYH, and Gheorghiade, M. "The immunological axis in heart failure: importance of the leukocyte differential." Heart Failure Reviews 18, no. 6 (November 2013): 835-845. (Review) Full Text
  - Maggioni, AP, Greene, SJ, Fonarow, GC, Böhm, M, Zannad, F, Solomon, SD, Lewis, EF, Baschiera, F, Hua, TA, Gimpelewicz, CR, Lesogor, A, Gheorghiade, M, and ASTRONAUT Investigators and Coordinators, . "Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial." European Heart Journal 34, no. 40 (October 2013): 3117-3127. Full Text
  - Gheorghiade, M, Greene, SJ, Ponikowski, P, Maggioni, AP, Korewicki, J, Macarie, C, Metra, M, Grzybowski, J, Bubenek-Turconi, S-I, Radziszewski, W, Olson, A, Bueno, OF, Ghosh, A, Deckelbaum, LI, Li, LY, Patel, AR, Koester, A, and Konstam, MA. "Haemodynamic effects, safety, and pharmacokinetics of human stresscopin in heart failure with reduced ejection fraction." European Journal of Heart Failure 15, no. 6 (June 2013): 679-689. Full Text
  - Gheorghiade, M, Patel, K, Filippatos, G, Anker, SD, van Veldhuisen, DJ, Cleland, JGF, Metra, M, Aban, IB, Greene, SJ, Adams, KF, McMurray, JJV, and Ahmed, A. "Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial." European Journal of Heart Failure 15, no. 5 (May 2013): 551-559. Full Text
  - Gheorghiade, M, Böhm, M, Greene, SJ, Fonarow, GC, Lewis, EF, Zannad, F, Solomon, SD, Baschiera, F, Botha, J, Hua, TA, Gimpelewicz, CR, Jaumont, X, Lesogor, A, Maggioni, AP, and ASTRONAUT Investigators and Coordinators, . "Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial." Jama 309, no. 11 (March 2013): 1125-1135. Full Text
  - Gheorghiade, M, Marti, CN, Sabbah, HN, Roessig, L, Greene, SJ, Böhm, M, Burnett, JC, Campia, U, Cleland, JGF, Collins, SP, Fonarow, GC, Levy, PD, Metra, M, Pitt, B, Ponikowski, P, Sato, N, Voors, AA, Stasch, J-P, Butler, J, and Academic Research Team in Heart Failure (ART-HF), . "Soluble guanylate cyclase: a potential therapeutic target for heart failure." Heart Failure Reviews 18, no. 2 (March 2013): 123-134. (Review) Full Text
  - Ambrosy, AP, Vaduganathan, M, Mentz, RJ, Greene, SJ, Subačius, H, Konstam, MA, Maggioni, AP, Swedberg, K, and Gheorghiade, M. "Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial." American Heart Journal 165, no. 2 (February 2013): 216-225. Full Text
  - Greene, SJ, Vaduganathan, M, Lupi, L, Ambrosy, AP, Mentz, RJ, Konstam, MA, Nodari, S, Subacius, HP, Fonarow, GC, Bonow, RO, Gheorghiade, M, and EVEREST Trial Investigators, . "Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial)." The American journal of cardiology 111, no. 4 (February 2013): 574-581. Full Text
  - Vaduganathan, M, Greene, SJ, Ambrosy, AP, Gheorghiade, M, and Butler, J. "The disconnect between phase II and phase III trials of drugs for heart failure." Nature Reviews. Cardiology 10, no. 2 (February 2013): 85-97. (Review) Full Text
  - Greene, SJ, Gheorghiade, M, Borlaug, BA, Pieske, B, Vaduganathan, M, Burnett, JC, Roessig, L, Stasch, J-P, Solomon, SD, Paulus, WJ, and Butler, J. "The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction." Journal of the American Heart Association 2, no. 6 (January 2013): e000536-null. (Review) Full Text
  - Lanfear, DE, Sabbah, HN, Goldsmith, SR, Greene, SJ, Ambrosy, AP, Fought, AJ, Kwasny, MJ, Swedberg, K, Yancy, CW, Konstam, MA, Maggioni, AP, Zannad, F, Gheorghiade, M, and EVEREST trial investigators, . "Association of arginine vasopressin levels with outcomes and the effect of V2 blockade in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial." Circulation. Heart Failure 6, no. 1 (January 2013): 47-52. Full Text
  - Greene, SJ, Harinstein, ME, Vaduganathan, M, Subačius, H, Konstam, MA, Zannad, F, Maggioni, AP, Swedberg, K, Butler, J, Gheorghiade, M, and EVEREST Trial Investigators, . "Prognostic value of monocyte count in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial)." The American Journal of Cardiology 110, no. 11 (December 2012): 1657-1662. Full Text
  - Vaduganathan, M, Ambrosy, AP, Greene, SJ, Mentz, RJ, Subacius, HP, Maggioni, AP, Swedberg, K, Nodari, S, Zannad, F, Konstam, MA, Butler, J, Gheorghiade, M, and EVEREST trial investigators, . "Predictive value of low relative lymphocyte count in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial." Circulation. Heart Failure 5, no. 6 (November 2012): 750-758. Full Text
  - Gheorghiade, M, Greene, SJ, Filippatos, G, Erdmann, E, Ferrari, R, Levy, PD, Maggioni, A, Nowack, C, Mebazaa, A, and COMPOSE Investigators and Coordinators, . "Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes." European Journal of Heart Failure 14, no. 9 (September 2012): 1056-1066. Full Text
- Conference Papers
  - Gheorghiade, M, Maggioni, AP, Lam, C, Samano, E, Kraigher-Krainer, E, Filippatos, G, Butler, J, Greene, SJ, Mueller, K, Roessig, L, Ponikowski, P, Shah, S, Solomon, SD, and Pieske, B. "Oral sGC Stimulator Vericiguat in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction - The SOluble guanylate Cyclase stimulatoR in heArT failurE patientS With REDUCED EF (SOCRATES-REDUCED) Study." December 8, 2015. Link to Item
  - Greene, SJ, Vaduganathan, M, Ambrosy, A, Konstam, M, Subacius, H, Maggioni, A, Mentz, R, Nodari, S, Butler, J, and Gheorghiade, M. "INFLUENCE OF URIC ACID LEVEL IN PATIENTS HOSPITALIZED FOR HEART FAILURE WITH REDUCED EJECTION FRACTION: INSIGHTS FROM THE EVEREST TRIAL." : Elsevier BV, March 2013. Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Selected Grants

Selected Publications

Academic Articles

Conference Papers